|
ATCC
l1210 murine lymphoblastic leukemia cells L1210 Murine Lymphoblastic Leukemia Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/l1210 murine lymphoblastic leukemia cells/product/ATCC Average 95 stars, based on 1 article reviews
l1210 murine lymphoblastic leukemia cells - by Bioz Stars,
2026-06
95/100 stars
|
Buy from Supplier |
|
ATCC
l1210 cells L1210 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/l1210 cells/product/ATCC Average 95 stars, based on 1 article reviews
l1210 cells - by Bioz Stars,
2026-06
95/100 stars
|
Buy from Supplier |
|
ATCC
l1210 mouse cell lines ![]() L1210 Mouse Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/l1210 mouse cell lines/product/ATCC Average 95 stars, based on 1 article reviews
l1210 mouse cell lines - by Bioz Stars,
2026-06
95/100 stars
|
Buy from Supplier |
Journal: EJHaem
Article Title: Innate Immune Cell Infiltration Induced by Polatuzumab Vedotin Contributes to the Antitumor Effect in Mouse Models
doi: 10.1002/jha2.70219
Figure Lengend Snippet: Pola‐induced infiltration of MΦs and NK cells contributes to the antitumor effect of Pola in the L1210‐hCD79b‐9 syngeneic mouse model. (A) Sensitivity of L1210 and L1210‐hCD79b‐9 cells to Pola at the indicated concentrations (3 replicates). The data represent the mean + SD. (B) Percentage of the area of CD68‐positive staining cells to the total area of tumor cells and (C) percentage of NCR1‐positive cells among tumor cells after 4 mg/kg ctrl IgG or 4 mg/kg Pola administration in the L1210‐hCD79b‐9 syngeneic mouse model ( n = 8). * p < 0.05 by Student's t ‐test. In dot plots, horizontal bars represent median values. (D) L1210‐hCD79b‐9 tumor growth curves from Day 0 to Day 9 after administration of 4 mg/kg ctrl IgG, 4 mg/kg Pola, or 4 mg/kg Pola plus clodronate liposomes plus anti‐asialo GM1 ( n = 6–7). (E) Numbers of mice presenting L1210‐hCD79b‐9 tumor regression on Day 9 following Pola administration. In vivo experiments (B–E) were conducted in DBA/2J mice. (F) Schematic diagram illustrating the relationship between the antitumor effect of Pola and innate immune cells.
Article Snippet: The DB (human) and
Techniques: Staining, Liposomes, In Vivo